Evusheld protects the vulnerable from Covid. Why are so few using it?
The drug was approved eight months ago as the best safeguard for immunocompromised patients. But the word does not seem to have spread far.
Source: statnews.com
Kee Conti News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Kee Conti. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Kee Conti Today - Breaking & Trending Today
Vulnerable patients scramble to get lifesaving anti-COVID drug
As society opens up and masks drop, an injection therapy that can stave off COVID-19 for...
Source: sfchronicle.com
Monoclonal antibodies can save lives. But Bay Area sees worryingly few takers
Bay Area clinics have ample supply of monoclonal antibodies, a lifesaving COVID...
Source: sfchronicle.com